Last reviewed · How we verify
Clarithromycin placebo tablets
Clarithromycin placebo tablets is a Small molecule drug developed by TenNor Therapeutics (Suzhou) Limited. It is currently in Phase 3 development for Control arm in phase 3 clinical trial (active indication unknown). Also known as: Clarithromycin placebo, Clarithromycin, ABT-268, Biaxin.
This is a placebo tablet with no active pharmacological mechanism.
This is a placebo tablet with no active pharmacological mechanism. Used for Control arm in phase 3 clinical trial (active indication unknown).
-
Baseline phase 3 → approval rate
+58.3pp
Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2028–2030 | — |
| EMA | EU | 2029–2031 | +0.7 yr |
| MHRA | GB | 2029–2031 | +0.7 yr |
| Health Canada | CA | 2029–2032 | +0.9 yr |
| TGA | AU | 2029–2032 | +1.2 yr |
| PMDA | JP | 2029–2032 | +1.5 yr |
| NMPA | CN | 2030–2033 | +2.3 yr |
| MFDS | KR | 2029–2032 | +1.4 yr |
| CDSCO | IN | 2029–2033 | +1.8 yr |
| ANVISA | BR | 2030–2033 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Clarithromycin placebo tablets |
|---|---|
| Also known as | Clarithromycin placebo, Clarithromycin, ABT-268, Biaxin, clarithromycin |
| Sponsor | TenNor Therapeutics (Suzhou) Limited |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Clarithromycin placebo tablets contain no active drug substance and are used as a control comparator in clinical trials. They are designed to be indistinguishable from active clarithromycin tablets to maintain blinding in phase 3 studies, allowing researchers to isolate the true therapeutic effect of the active drug from placebo response.
Approved indications
- Control arm in phase 3 clinical trial (active indication unknown)
Common side effects
Key clinical trials
- Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans (PHASE3)
- Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) (PHASE3)
- Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori (PHASE3)
- Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection (PHASE3)
- Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori (PHASE3)
- Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia (PHASE3)
- Electrophysiological Effects of Potential QT Prolonging Drugs (PHASE1)
- Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clarithromycin placebo tablets CI brief — competitive landscape report
- Clarithromycin placebo tablets updates RSS · CI watch RSS
- TenNor Therapeutics (Suzhou) Limited portfolio CI
Frequently asked questions about Clarithromycin placebo tablets
What is Clarithromycin placebo tablets?
How does Clarithromycin placebo tablets work?
What is Clarithromycin placebo tablets used for?
Who makes Clarithromycin placebo tablets?
Is Clarithromycin placebo tablets also known as anything else?
What development phase is Clarithromycin placebo tablets in?
Related
- Manufacturer: TenNor Therapeutics (Suzhou) Limited — full pipeline
- Indication: Drugs for Control arm in phase 3 clinical trial (active indication unknown)
- Also known as: Clarithromycin placebo, Clarithromycin, ABT-268, Biaxin, clarithromycin
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing